Moderna

The FDA has approved Moderna's new mRNA-based vaccine for influenza. The vaccine is to be used for adults over the age of 50.

Reviewers with the Food and Drug Administration (FDA) announced that Moderna's flu vaccine made with mRNA technology is "effective."

European regulators approved a combination Moderna vaccine targeting COVID-19 and influenza.

Europe's medical regulator, the European Medicines Agency, recommended the approval of Moderna's COVID-19-flu vaccine.

The FDA has now agreed to review an application from Moderna concerning its mRNA influenza vaccine after previously denying the company's effort.

Moderna will receive up to $54.3 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of the pharmaceutical company's mRNA-based pandemic flu vaccine.

The Department of Health and Human Services (HHS) canceled a contract with Moderna to develop a bird flu vaccine.

Respiratory Syncytial Virus (RSV) vaccines from GSK and Pfizer will carry warnings for an increased risk of Guillain-Barré syndrome (GBS), the U.S. Food Drug Administration (FDA) said.

On December 31, 2024, a San Diego police officer rescued a non-breathing one-year-old infant in Point Loma. Around 1:35 p.m., a woman frantically called police about a baby not breathing in the 1100 block of Sunset Cliffs Boulevard.

A California family filed a lawsuit earlier this year against health clinic Amazon One Medical after a man died following a virtual consultation.